Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Research & Development: 2018-2021

Historic Research & Development for Black Diamond Therapeutics (BDTX) over the last 4 years, with Dec 2021 value amounting to $96.8 million.

  • Black Diamond Therapeutics' Research & Development rose 10.75% to $19.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $87.9 million, marking a year-over-year increase of 93.12%. This contributed to the annual value of $96.8 million for FY2021, which is 100.85% up from last year.
  • As of FY2021, Black Diamond Therapeutics' Research & Development stood at $96.8 million, which was up 100.85% from $48.2 million recorded in FY2020.
  • Black Diamond Therapeutics' Research & Development's 5-year high stood at $96.8 million during FY2021, with a 5-year trough of $7.0 million in FY2018.
  • In the last 3 years, Black Diamond Therapeutics' Research & Development had a median value of $48.2 million in 2020 and averaged $55.6 million.
  • Data for Black Diamond Therapeutics' Research & Development shows a peak YoY surged of 212.99% (in 2019) over the last 5 years.
  • Yearly analysis of 4 years shows Black Diamond Therapeutics' Research & Development stood at $7.0 million in 2018, then surged by 212.99% to $21.8 million in 2019, then surged by 121.62% to $48.2 million in 2020, then skyrocketed by 100.85% to $96.8 million in 2021.